Proteomic evidence of specific IGKV1-8 association with cystic lung light chain deposition disease.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
27 06 2019
Historique:
received: 22 01 2019
accepted: 19 03 2019
pubmed: 11 4 2019
medline: 10 1 2020
entrez: 11 4 2019
Statut: ppublish

Résumé

We previously reported a new form of light chain deposition disease (LCDD) presenting as diffuse cystic lung disorder that differs from the usual systemic form with respect to patient age, the male/female ratio, the involved organs, and the hematologic characteristics. We also demonstrated that the light chains were produced by an intrapulmonary B-cell clone and that this clone shared a stereotyped antigen receptor IGHV4-34/IGKV1. However, we only analyzed 3 patients. We conducted a retrospective study including lung tissue samples from 24 patients with pulmonary LCDD (

Identifiants

pubmed: 30967366
pii: S0006-4971(20)42453-X
doi: 10.1182/blood.2019898577
doi:

Substances chimiques

Immunoglobulin Light Chains 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2741-2744

Informations de copyright

© 2019 by The American Society of Hematology.

Auteurs

Mylène Camus (M)

Département d'Anatomie Pathologique, Institut Universitaire du Cancer, Toulouse, France.
Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Centre National de la Recherche Scientifique, Université Paul Sabatier, Toulouse, France.

Sandrine Hirschi (S)

Service de Pneumologie, Centre Hospitalier Universitaire (CHU) Strasbourg, Strasbourg, France.

Grégoire Prevot (G)

Service de Pneumologie, CHU Toulouse, Toulouse, France.

Marie-Pierre Chenard (MP)

Département d'Anatomie et Cytologie Patologiques, CHU Strasbourg, Strasbourg, France.

Hervé Mal (H)

Service de Pneumologie, Hôpital Bichat, Paris, France.

Marc Stern (M)

Service de Pneumologie, Hôpital Foch, Suresnes, France.

Martine Reynaud-Gaubert (M)

Service de Pneumologie, CHU Marseille, Marseille, France.

Julia Gilhodes (J)

Service de Biostatistiques, Institut Claudius Regaud Institut Universitaire du Cancer-O, Toulouse, France; and.

Odile Burlet-Schiltz (O)

Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Centre National de la Recherche Scientifique, Université Paul Sabatier, Toulouse, France.

Pierre Brousset (P)

Département d'Anatomie Pathologique, Institut Universitaire du Cancer, Toulouse, France.
Labex Toucan, Toulouse, France.

Magali Colombat (M)

Département d'Anatomie Pathologique, Institut Universitaire du Cancer, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH